SB 1091 Pennsylvania Senate · 2021-2022 Regular Session

An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.

Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2022
Committee Review
Floor Vote
Governor
Introduced Feb 23, 2022 Last action Feb 23, 2022
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
1
Feb 23, 2022
Committee
PN 1424 Referred to HEALTH AND HUMAN SERVICES
upper
1 primary · 4 co-sponsors

Sponsors